{"disease":{"id":"embryonal-botryoid-childhood-rhabdomyosarcoma","name":"embryonal botryoid childhood rhabdomyosarcoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00075582","title":"Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":390,"lead_sponsor_name":"Children's Oncology Group","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}